These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37716525)

  • 41. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
    Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J
    J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
    [TBL] [Abstract][Full Text] [Related]  

  • 42. C1-inhibitor deficiency and angioedema.
    Carugati A; Pappalardo E; Zingale LC; Cicardi M
    Mol Immunol; 2001 Aug; 38(2-3):161-73. PubMed ID: 11532278
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
    Lumry WR; Zuraw B; Cicardi M; Craig T; Anderson J; Banerji A; Bernstein JA; Caballero T; Farkas H; Gower RG; Keith PK; Levy DS; Li HH; Magerl M; Manning M; Riedl MA; Lawo JP; Prusty S; Machnig T; Longhurst H;
    Orphanet J Rare Dis; 2021 Feb; 16(1):86. PubMed ID: 33588897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
    Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
    Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients.
    Federici C; Perego F; Borsoi L; Crosta V; Zanichelli A; Gidaro A; Tarricone R; Cicardi M
    BMJ Open; 2018 Jul; 8(7):e022291. PubMed ID: 30061443
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.
    Castelli R; Zanichelli A; Cugno M
    Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):181-90. PubMed ID: 23137231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema.
    Valerieva A; Caccia S; Cicardi M
    Expert Rev Clin Immunol; 2018 Sep; 14(9):707-718. PubMed ID: 30021471
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Characteristics and Safety of Plasma-Derived C1-Inhibitor Therapy in Children and Adolescents with Hereditary Angioedema-A Long-Term Survey.
    Farkas H; Kőhalmi KV; Visy B; Veszeli N; Varga L
    J Allergy Clin Immunol Pract; 2020; 8(7):2379-2383. PubMed ID: 32198128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HEREDITARY ANGIOEDEMA DUE TO C1-INHIBITOR DEFICIENCY IN PEDIATRIC PATIENTS IN CROATIA - FIRST NATIONAL STUDY, DIAGNOSTIC AND PROPHYLACTIC CHALLENGES.
    Karadža-Lapić L; Barešić M; Vrsalović R; Ivković-Jureković I; Sršen S; Prkačin I; Rijavec M; Cikojević D
    Acta Clin Croat; 2019 Mar; 58(1):139-146. PubMed ID: 31363336
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C1 Inhibitor Activity and Angioedema Attacks in Patients with Hereditary Angioedema.
    Kaplan AP; Pawaskar D; Chiao J
    J Allergy Clin Immunol Pract; 2020 Mar; 8(3):892-900. PubMed ID: 31655295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acquired C1 Inhibitor Deficiency.
    Otani IM; Banerji A
    Immunol Allergy Clin North Am; 2017 Aug; 37(3):497-511. PubMed ID: 28687105
    [TBL] [Abstract][Full Text] [Related]  

  • 52. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
    Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
    Bork K
    Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C1-inhibitor/C1-inhibitor antibody complexes in acquired angioedema due to C1-inhibitor deficiency.
    Polai Z; Kajdacsi E; Cervenak L; Balla Z; Benedek S; Varga L; Farkas H
    Orphanet J Rare Dis; 2023 Feb; 18(1):24. PubMed ID: 36726161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Guidelines for the diagnosis and treatment of hereditary angioedema].
    Marković AS; Rozmanić V; Anić B; Aberle N; Racić G; Novak S; Sunara D; Grdinić B; Karadza-Lapić L; Radas MR; Karanović B; Kvenić B
    Lijec Vjesn; 2014; 136(5-6):117-29. PubMed ID: 25154179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.
    Bork K; Bernstein JA; Machnig T; Craig TJ
    J Emerg Med; 2016 Apr; 50(4):567-80.e1. PubMed ID: 26826769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrate.
    Zuraw BL; Cicardi M; Longhurst HJ; Bernstein JA; Li HH; Magerl M; Martinez-Saguer I; Rehman SM; Staubach P; Feuersenger H; Parasrampuria R; Sidhu J; Edelman J; Craig T
    Allergy; 2015 Oct; 70(10):1319-28. PubMed ID: 26016741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety.
    Hofstra JJ; Kleine Budde I; van Twuyver E; Choi G; Levi M; Leebeek FW; de Monchy JG; Ypma PF; Keizer RJ; Huitema AD; Strengers PF
    Clin Immunol; 2012 Mar; 142(3):280-90. PubMed ID: 22197071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acquired Angioedema in Selected Neoplastic Diseases.
    Zając M; Bożek A; Kozłowska R; Grzanka A
    Medicina (Kaunas); 2023 Mar; 59(4):. PubMed ID: 37109602
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor.
    Jones DH; Bansal P; Bernstein JA; Fatteh S; Harper J; Hsu FI; O'Connor M; Park N; Suez D
    World Allergy Organ J; 2022 Jan; 15(1):100621. PubMed ID: 35145604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.